The Journal of Urology · 1984 · 54 citations · 25 references
MedicineOncologyUrologyGenitourinary OncologyGlycobiologyProstate DiseaseBenign Prostatic HyperplasiaExtracellular Matrix GlycansProstate CancerProstate DisordersProstate PathologyProstatic PathologyDermatan SulfateExtracellular Matrix ProteoglycansGlycosaminoglycan ContentHeparan Sulfate In CancerHeparan Sulfate ProteoglycansProstate Stromal-epithelial InteractionsProstatic AdenocarcinomaProstatic Stroma
The glycosaminoglycans of normal, benign hyperplastic and cancerous prostate were studied. In both prostatic hyperplasia and cancer the chondroitin sulfate:dermatan sulfate ratio was increased. In prostatic cancer this increase correlated with both the differentiation and extent of cancer in the prostate. The percentages heparan sulfate and heparan sulfate sulfation were decreased in prostatic cancer. Hyaluronic acid increased with dedifferentiation of the cancer. Histochemically, sulfated glycosaminoglycans were concentrated in the prostatic stroma at the stromal-epithelial interface. The increased chondroitin sulfate:dermatan sulfate ratio may be a nonspecific response or requirement for epithelial growth.
25
A modified uronic acid carbazole reaction
Thomas Bitter, H. M. Muir · Analytical Biochemistry · 1962 · 6.3K citations
Purification and Properties of Bacterial Chondroitinases and Chondrosulfatases
T Yamagata, Hidehiko Saito, Osami Habuchi et al. · Journal of Biological Chemistry · 1968 · 1.2K citations · Full text